Mark R. Deziel
Institute for Clinical Pharmacodynamics (United States)(US)
Publications by Year
Research Areas
Antibiotics Pharmacokinetics and Efficacy, Antibiotic Resistance in Bacteria, Pneumonia and Respiratory Infections, Erythrocyte Function and Pathophysiology, Pancreatic function and diabetes
Most-Cited Works
- → Concentration-Dependent Mycobacterium tuberculosis Killing and Prevention of Resistance by Rifampin(2007)340 cited
- → Selection of a Moxifloxacin Dose That Suppresses Drug Resistance inMycobacterium tuberculosis,by Use of an In Vitro Pharmacodynamic Infection Model and Mathematical Modeling(2004)317 cited
- → Application of a mathematical model to prevent in vivo amplification of antibiotic-resistant bacterial populations during therapy(2003)239 cited
- → Pharmacodynamics of Caspofungin in a Murine Model of Systemic Candidiasis: Importance of Persistence of Caspofungin in Tissues to Understanding Drug Activity(2005)164 cited
- → The Relationship between Quinolone Exposures and Resistance Amplification Is Characterized by an Inverted U: a New Paradigm for Optimizing Pharmacodynamics To Counterselect Resistance(2006)128 cited
- → Bacterial‐Population Responses to Drug‐Selective Pressure: Examination of Garenoxacin's Effect onPseudomonas aeruginosa(2005)105 cited
- → Impact of Drug‐Exposure Intensity and Duration of Therapy on the Emergence ofStaphylococcus aureusResistance to a Quinolone Antimicrobial(2007)91 cited
- → Pharmacodynamic Evidence that Ciprofloxacin Failure against Tuberculosis Is Not Due to Poor Microbial Kill but to Rapid Emergence of Resistance(2005)72 cited
- → Anidulafungin Pharmacokinetics and Microbial Response in Neutropenic Mice with Disseminated Candidiasis(2006)71 cited